Compare Enveric Biosciences Inc (ENVB) vs Funko Inc (FNKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Funko Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Funko Inc trades at $6.49 (market cap $363.97M). The key difference: Funko Inc is far larger — about 53.5× Enveric Biosciences Inc's market cap, and Funko Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Funko Inc for 33 Days on average.
| ENVB | FNKO | |
|---|---|---|
Market Cap | $6.80M | $363.97M |
Volume | 64,867 | 1,422,651 |
Sector | Health | Consumer Cyclical |
52-Week High | $10.80 | $7.10 |
52-Week Low | $1.27 | $2.81 |
Typical Hold Time | 14 Days | 33 Days |
Enterprise Value | -$1.49M | $584.62M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
FNKO trades at $6.31, up 3.27% with strong technical momentum and bullish moving average signals. The stock shows improving fundamentals with recent earnings beats and raised EBITDA guidance, though profitability remains challenged with negative net margins. Analyst consensus leans Hold with a $7.58 price target, representing 20% upside potential from current levels.
The outlook suggests cautious optimism as operational improvements and debt reduction progress, but investors face risks from inconsistent profitability and competitive pressures in the collectibles market. The stock's attractive valuation multiples and recent management changes provide potential catalysts for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →
